These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 11894663)

  • 21. [Hepatitis B (acute and chronic)].
    Kolyvanos Naumann U; Käser L; Vetter W
    Praxis (Bern 1994); 2004 Jul; 93(31-32):1227-33; quiz 1234, 1261. PubMed ID: 15453144
    [No Abstract]   [Full Text] [Related]  

  • 22. Hepatitis B: Treatment to prevent perinatal transmission.
    Tran TT
    Clin Obstet Gynecol; 2012 Jun; 55(2):541-9. PubMed ID: 22510637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B vaccine alone or in combination with anti-HBs immunoglobulin in the perinatal prophylaxis of babies born to HBsAg carrier mothers.
    Sehgal A; Gupta I; Sehgal R; Ganguly NK
    Acta Virol; 1992 Aug; 36(4):359-66. PubMed ID: 1362320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of perinatal hepatitis B through enhanced case management--Connecticut, 1994-95, and the United States, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1996 Jul; 45(27):584-7. PubMed ID: 9132578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current topics in hepatitis B.
    Zuckerman JN; Zuckerman AJ
    J Infect; 2000 Sep; 41(2):130-6. PubMed ID: 11023756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
    Lim SG; Mohammed R; Yuen MF; Kao JH
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B testing and vaccination in patients recently diagnosed with HIV infection(Int J STD AIDS 2008;19:83-4).
    Brook MG; Rubinstein L; King G
    Int J STD AIDS; 2008 Jul; 19(7):501. PubMed ID: 18574131
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B vaccination in children: the Taiwan experience.
    Ni YH; Chen DS
    Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B virus serologic markers and anti-hepatitis B vaccination in patients with diabetes.
    Halota W; Muszyńska M; Pawłowska M
    Med Sci Monit; 2002 Jul; 8(7):CR516-9. PubMed ID: 12118201
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Differential diagnosis of Hepatitis A, B, C, D and E. Clinical, biochemical and viral serologic criteria. 3: Serology--hepatitis B].
    Eisenburg J
    Fortschr Med; 1995 Jan; 113(1-2):41-2, 45. PubMed ID: 7883265
    [No Abstract]   [Full Text] [Related]  

  • 32. Program to prevent perinatal hepatitis B virus transmission in a health-maintenance organization--Northern California, 1990-1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 May; 46(17):378-80. PubMed ID: 9148143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B reactivation in a hepatitis B surface antigen-negative patient after allogeneic bone marrow transplant: successful treatment with lamivudine and seroconversion.
    Pérez-Grande R; Gutiérrez-Zufiaurre N; Muñoz-Criado S; Blázquez de Castro AM; Vázquez López L; González San Martín F; García Rodríguez JA; Muñoz Bellido JL
    Diagn Microbiol Infect Dis; 2009 May; 64(1):80-2. PubMed ID: 19304434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 35. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation.
    Hashino S; Nozawa A; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Hige S; Asaka M
    Bone Marrow Transplant; 2002 Feb; 29(4):361-3. PubMed ID: 11896435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan.
    Suzuki Y; Kobayashi M; Ikeda K; Suzuki F; Arfase Y; Akuta N; Hosaka T; Saitoh S; Kobayashi M; Someya T; Matsuda M; Sato J; Watabiki S; Miyakawa Y; Kumada H
    J Med Virol; 2005 May; 76(1):33-9. PubMed ID: 15779048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A study on serologic markers for screening before hepatitis B vaccination].
    Hui Z; Zhao Z; Zhang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):351-3. PubMed ID: 7874705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prophylactic effect of antiretroviral therapy on hepatitis B virus infection.
    Gatanaga H; Hayashida T; Tanuma J; Oka S
    Clin Infect Dis; 2013 Jun; 56(12):1812-9. PubMed ID: 23487374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Etiology, diagnosis and the prospects for vaccinal prevention hepatitis B].
    Anan'ev VA
    Vestn Akad Med Nauk SSSR; 1983; (12):37-40. PubMed ID: 6229935
    [No Abstract]   [Full Text] [Related]  

  • 40. [Vaccination and serologic markers of hepatitis B virus infection].
    Salmeron Garcia F; Echevarria Mayo JM
    Rev Sanid Hig Publica (Madr); 1990; 64(3-4):141-50. PubMed ID: 2131596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.